Tylenol Use During Pregnancy Linked to Autism: Trump Administration's Upcoming Announcement

The administration under Trump is preparing to declare a significant connection between the consumption of Tylenol by expectant mothers and the development of autism in their children.

According to reports, federal health officials will soon advise against the early use of Tylenol by pregnant women, unless deemed necessary for fever management. This recommendation came from a Washington Post article that quoted several sources close to the case. Moreover, officials are set to promote a form of folate, leucovorin, as a promising option for autism treatment.

Requests for a statement from the Department of Health and Human Services and the White House were not immediately answered by CNBC.

President Trump hinted at a significant announcement related to autism policy, anticipating it as one of the vital actions taken by his administration, which he indicated during comments made at an event supported by the American Cornerstone Institute.

Rumors had surfaced that HHS Secretary Robert F. Kennedy Jr. would soon release findings connecting acetaminophen, the active component in Tylenol, to autism when used during pregnancy. This led to a noticeable dip in Tylenol's parent company's stock value.

Attempts to get a comment from Kenvue, another pharmaceutical entity, did not yield any response.

In light of media reports, Tylenol representatives reiterated the absence of confirmed evidence linking acetaminophen use with autism.

Kenvue CEO Kirk Perry previously met with Robert F. Kennedy Jr. to emphasize their stance and persuaded him to reconsider naming Tylenol as a probable autism cause. This meeting was based on separate reporting.

Executives from Kenvue pointed out the limited alternatives for managing fever in pregnant women that match acetaminophen’s safety profile.

Health advisories consistently suggest that acetaminophen can be consumed safely during pregnancy if used as instructed, urging people to seek healthcare provider guidance for any medication taken during this sensitive period.

Notably, addressing autism is a pivotal task for Kennedy at HHS, as he is committed to investigating the roots of this complex condition. His past efforts include shedding light on autism’s growing prevalence and potential causative elements.